Antagonistic Effects of Anti-EMMPRIN Antibody When Combined with Chemotherapy Against Hypovascular Pancreatic Cancers

Hyunki Kim,Christopher Rigell,Guihua Zhai,S. Kyle Lee,Sharon Samuel,Amber Martin,Heidi Umphrey,Cecil R. Stockard,T. Mark Beasley,Donald J. Buchsbaum,Long Shan Li,David A. Boothman,Kurt R. Zinn

Antagonistic Effects of Anti-EMMPRIN Antibody When Combined with Chemotherapy Against Hypovascular Pancreatic Cancers

2014

Hyunki Kim
Christopher Rigell
Guihua Zhai
S. Kyle Lee
Sharon Samuel
Amber Martin
Heidi Umphrey
Cecil R. Stockard
T. Mark Beasley
Donald J. Buchsbaum
Long Shan Li
David A. Boothman
Kurt R. Zinn

Purpose To examine the antagonistic effects of anti-extracellular matrix metalloprotease inducer (anti-EMMPRIN) antibody when combined with chemotherapy using a hypovascular pancreatic tumor model.

Keywords:

Radiology
Antibody
Medicine
Positron emission tomography
Pancreatic cancer
Pancreatic tumor
Deoxycytidine
Gemcitabine
Oncology
Deoxyglucose
Chemotherapy
Internal medicine
Inducer
Matrix Metalloprotease

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations